15 September 2010 15:56 [Source: ICIS news]
TORONTO (ICIS)--Canadian biofuels firm Iogen Corporation has hired Goldman Sachs for a strategic review, triggering speculation on Wednesday that the company may be for sale.
“The board of directors feels that it is appropriate to examine all alternatives which will allow the company to realise the potential of this technology and thereby maximise shareholder value," Iogen chairman Clive Mather said in a statement late on Tuesday.
Iogen did not clarify what it meant by “all alternatives”. Such wording usually implies that a company may put itself up for sale, or enter into a merger or partnership.
An Iogen spokesperson did not return a call requesting comment.
Mather, a former chief executive of Shell Canada, said Iogen had developed advanced biofuel technology that was ready to be deployed.
According to its website, Iogen owns and operates a 10-acre, enzyme and cellulosic ethanol plant in ?xml:namespace>
In addition to the biofuels business, Iogen also has a commercial enzyme business.
Earlier this month,
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections